Novel mechanism of HIV-RT inhibition by NNRTI

An interesting paper published recently in Angewandte demonstrating that a compound which binds to an allosteric site on an enzyme can behave like a competitive inhibitor.

Non-nucleoside reverse transcriptase inhibitors are structurally and mechanistically unique compared to the more traditional nucleoside inhibitors and are included as a component of one of the most recommended therapies for HIV. The story behind this class of compounds is interesting, but best left for another time, needless to say they are distinguished from the nucleosides in thier ability to bind to an allosteric site on RT and act as non-competitive inhibitors (they reduce kcat not KM). One such compound is TNK-651 (or HEPT) which is a pure noncompetitive inhibitor. Based on this Maga et al. made a library of pyrimidine based compounds which included compound 1  (Ki= 8 nM) and similar analogues but found that they were competitive with the nucleotide substrate (apparent KMincreased with increasin concentrations of 1).

The interesting part came when they saw that these compounds were sensitve to the same resistance mutations as TNK-651. These mutations are located around the allosteric binding site and lead to resistance to TNK-651 and other NNRTIs. The fact that these mutations also lead to resistance to 1 indicates that it is binding at the allosteric site not at the active site. In order for this to work you have to assume that binding of 1 to the allosteric site causes a significant conformational distortion in the substrate nucleotide binding site such that its affinity is dramaticlly lowered. Of course in order for the compound to be truely competive the opposite should be true as well, binding of the substrate should distort the allosteric pocket and reduce the binding of affinity of 1.

I don’t claim to be an expert on enzyme/inhibitor kinetics so I don’t know if any other proposal could explain thier data. I would be interested to know if there are alternative interpretations.



2 Responses to “Novel mechanism of HIV-RT inhibition by NNRTI”

  1. TotallyMedicinal Says:

    2-methanesulfonyl pyrimidines (such as 1) are extremely reactive. Add on a dimethylamino group at the 4-position, and these molecules must be primed to self-destruct at the merest hint of an aqueous environment. I can’t access the original article, but these must be irreversible inhibitors – either that or the active species is the hydrolysed pyrimidin-2-one?

  2. walkerma Says:

    We have worked with similar compounds…I agree, I would be concerned about that the C2-site as well. I suspect that compound 1 was a synthetic intermediate. I have not looked at the assay conditions, which are in the supplmental material, so I don’t know if they observed any time-dependent activity.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: